Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive (loss) Income
Beginning balance at Dec. 31, 2023	$ 62,824	$ 6	$ 138,657	$ (75,780)	$ (59)
Beginning balance, shares at Dec. 31, 2023		58,751,666
Issuance of common stock upon exercise of stock options	250		250
Issuance of common stock upon exercise of stock options, shares		755,016
Stock-based compensation expense	2,505		2,505
Issuance of common stock in connection with the acquisition of fSight, shares		166,271
Issuance of common stock in connection with the acquisition of fSight	239		239
Issuance of common stock in connection with employee incentive restricted stock awards, shares		685,213
Unrealized gain (loss) resulting from change in fair value of marketable securities	12				12
Net loss	(11,506)			(11,506)
Ending balance, shares at Mar. 31, 2024		60,358,166
Ending balance at Mar. 31, 2024	54,324	$ 6	141,651	(87,286)	(47)
Beginning balance at Dec. 31, 2024	8,385	$ 6	146,903	(138,526)	2
Beginning balance, shares at Dec. 31, 2024		60,800,130
Issuance of common stock upon exercise of stock options	$ 2		2
Issuance of common stock upon exercise of stock options, shares	2,334	2,334
Stock-based compensation expense	$ 1,576		1,576
Issuance of common stock in connection with the acquisition of fSight	815
Issuance of common stock in connection with employee incentive restricted stock awards, shares		127,500
Issuance of common stock in connection with at-the-market offering, net of offering costs, shares		984,966
Issuance of common stock in connection with at-the-market offering, net of offering costs			815
Shares withheld for taxes upon restricted stock awards vesting, shares		(411)
Unrealized gain (loss) resulting from change in fair value of marketable securities	(2)				$ (2)
Net loss	(7,001)			(7,001)
Ending balance, shares at Mar. 31, 2025		61,914,519
Ending balance at Mar. 31, 2025	$ 3,775	$ 6	$ 149,296	$ (145,527)